Corpus ID: 29151977

Diagnostic and Treatment Strategies of Dermatologists for Treating Morphea in Hungary.

@article{Bali2018DiagnosticAT,
  title={Diagnostic and Treatment Strategies of Dermatologists for Treating Morphea in Hungary.},
  author={G. Bali and B. Hidv{\'e}gi},
  journal={Acta dermatovenerologica Croatica : ADC},
  year={2018},
  volume={26 1},
  pages={
          21-24
        }
}
Localized scleroderma is an uncommon disease, only infrequently encountered by dermatologists in private practices or even in larger academic centers. Because of its rarity, current treatment guidelines are mostly based on low-level clinical evidence and expert opinions. The aim of this study was to evaluate treatment strategies to treat localized scleroderma. A questionnaire was developed and sent to dermatologists in Hungary. 101 returned questionnaires were eligible for evaluation. 87.12% of… Expand

References

SHOWING 1-5 OF 5 REFERENCES
Treatment of Pediatric Localized Scleroderma: Results of a Survey of North American Pediatric Rheumatologists
TLDR
Most PR in North America treat localized scleroderma with a combination of MTX and corticosteroids, however, there is no consensus on specific treatment regimens and a need for controlled treatment trials to better determine optimal therapy for this potentially disabling disease. Expand
Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment.
TLDR
Patients with morphea experience delay in diagnosis, which likely impacts outcome, and underscores the need for a collaborative, multispecialty approach in designing therapeutic trials and guidelines. Expand
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
TLDR
Clinicians are provided with an overview of the diagnosis and treatment of localized scleroderma, systemic sclerosis including overlap syndromes of systemic sclerosis with diseases of the rheumatological spectrum. Expand
Update on morphea: part II. Outcome measures and treatment.
  • N. Fett, V. Werth
  • Medicine
  • Journal of the American Academy of Dermatology
  • 2011
TLDR
The Localized Scleroderma Cutaneous Assessment Tool is a promising recently validated skin scoring tool that allows differentiation between activity and damage, is sensitive to change, and requires no additional equipment. Expand
Management of morphoea: results of a national survey of U.K. clinicians
TLDR
It is confirmed that the DH rash is effectively controlled by a strict GFD from childhood to adolescence and then in adulthood, and that when DH is diagnosed in childhood or adulthood, a dermatologist should inform the patient about the possibility that family members or relatives may develop coeliac disease or DH. Expand